📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Penumbra

1.1 - Company Overview

Penumbra Logo

Penumbra

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of neurovascular and peripheral vascular devices, including: Lightning Flash mechanical thrombectomy for pulmonary embolism and venous thrombus; Penumbra System for mechanical thrombectomy in acute ischemic stroke due to intracranial large vessel occlusions; Artemis Neuro Evacuation Device for controlled aspiration; Indigo System for arterial/venous clot removal; PC400 coils for aneurysms and malformations; and POD400/PAC400 for predictable vessel occlusion.

Products and services

  • Penumbra System: A custom-engineered mechanical thrombectomy system targeting acute ischemic stroke due to intracranial large vessel occlusions, built to perform clot removal
  • Indigo System: An industrial-grade thrombectomy system engineered to remove clots from arteries and veins in the peripheral vasculature, including treatment of pulmonary embolism
  • Lightning Flash: A modular mechanical thrombectomy system built for treatment of pulmonary embolism and venous thrombus

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Penumbra

Cerus Endovascular Logo

Cerus Endovascular

HQ: United Kingdom Website
  • Description: Provider of interventional neuroradiology devices and delivery systems, including the e-clipse aneurysm occlusive device that addresses neurovascular aneurysm procedures currently attempted by surgical clipping, minimally invasive metal coils, and liquid embolics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cerus Endovascular company profile →
Allon Therapeutics Logo

Allon Therapeutics

HQ: Canada Website
  • Description: Provider of clinical-stage biopharmaceutical drug development for neurodegenerative diseases, with lead product Davunetide intranasal in Phase IIa clinical trials for Alzheimer's disease, schizophrenia cognitive impairment, and frontotemporal.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Allon Therapeutics company profile →
Mitokinin Logo

Mitokinin

HQ: United States Website
  • Description: Provider of biotechnology R&D focused on medicinal chemistry to generate kinetin analogs optimized for activating PINK1, with plans to develop these analogs or optimized variants to treat Parkinson's disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mitokinin company profile →
CuraSen Therapeutics Logo

CuraSen Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies for neurodegenerative diseases, developing orphan drugs including CST-103/CST-107, a combination therapy targeting cognitive symptoms and disease progression in Parkinson’s disease (Phase 2); CST-2032/CST-107 for Alzheimer’s disease with similar focus (Phase 2); and CST-3056, an alpha-1A adrenoceptor agonist in preclinical development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CuraSen Therapeutics company profile →
Eleusian Biosciences Logo

Eleusian Biosciences

HQ: Canada Website
  • Description: Provider of therapeutics in development for multiple pathological psychological diseases, based on psilocybin plus N-acetylcysteine (NAC) compounds.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eleusian Biosciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Penumbra

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Penumbra

2.2 - Growth funds investing in similar companies to Penumbra

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Penumbra

4.2 - Public trading comparable groups for Penumbra

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Penumbra

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Penumbra

What does Penumbra do?

Penumbra is a provider of neurovascular and peripheral vascular devices, including: Lightning Flash mechanical thrombectomy for pulmonary embolism and venous thrombus; Penumbra System for mechanical thrombectomy in acute ischemic stroke due to intracranial large vessel occlusions; Artemis Neuro Evacuation Device for controlled aspiration; Indigo System for arterial/venous clot removal; PC400 coils for aneurysms and malformations; and POD400/PAC400 for predictable vessel occlusion.

Who are Penumbra's competitors?

Penumbra's competitors and similar companies include Cerus Endovascular, Allon Therapeutics, Mitokinin, CuraSen Therapeutics, and Eleusian Biosciences.

Where is Penumbra headquartered?

Penumbra is headquartered in United States.

How many employees does Penumbra have?

Penumbra has 1,000 employees 🔒.

When was Penumbra founded?

Penumbra was founded in 2010 🔒.

What sector and industry vertical is Penumbra in?

Penumbra is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Penumbra

Who are the top strategic acquirers in Penumbra's sector and industry

Top strategic M&A buyers and acquirers in Penumbra's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Penumbra?

Top strategic M&A buyers groups and sectors for Penumbra include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Penumbra's sector and industry vertical

Which are the top PE firms investing in Penumbra's sector and industry vertical?

Top PE firms investing in Penumbra's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Penumbra's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Penumbra's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Penumbra's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Penumbra include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Penumbra's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Penumbra?

The key public trading comparables and valuation benchmarks for Penumbra include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Penumbra for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Penumbra with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Penumbra's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Penumbra with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Penumbra's' sector and industry vertical?

Access recent funding rounds and capital raises in Penumbra's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Penumbra

Launch login modal Launch register modal